Nightingale Health Plc – Managers’ transactions – Teemu Suna
Nightingale Health Plc – Managers' Transactions – 31 October 2022 2.30 p.m. (EET)
____________________________________________
Person subject to the notification requirement
Name: Suna, Teemu
Position: Chief Executive Officer
Issuer: Nightingale Health Oyj
LEI: 743700WUIPC24LVMLO66
Notification type: INITIAL NOTIFICATION
Reference number: 20698/7/6
____________________________________________
Transaction date: 2022-10-28
Venue: FIRST NORTH GROWTH MARKET FINLAND (FSME)
Instrument type: SHARE
ISIN: FI4000490875
Nature of the transaction: ACQUISITION
Transaction details
(1): Volume: 331 Unit price: 1.16 EUR
(2): Volume: 8,169 Unit price: 1.16 EUR
Aggregated transactions
(2): Volume: 8,500 Volume weighted average price: 1.16 EUR
For further information, please contact:
Teemu Suna, CEO
[email protected]
Certified Adviser:
Oaklins Merasco Ltd, tel. +358 9 6129 670
About Nightingale Health
Nightingale Health is The Preventative Health Company. Staying healthy is one of the top priorities in human life. Our health has a profound impact on our quality of life, and it’s also strongly connected to the lives of those close to us. Nightingale Health enables prevention by combining the power of our in-house developed, advanced blood analysis technology with unprecedented access to global health repositories and world-leading medical research. With this combination, we go beyond the traditional healthcare and wellbeing tools: We provide the scientific connection to multiple health and disease outcomes and the ability to predict future healthy years.
